Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients

Acea Nebril, Benigno; García Novoa, Alejandra; Bouzón Alejandro, Alberto; Diaz Carballada, Carlota Czestokowa; Conde Iglesias, Carmen

doi:10.1016/j.breast.2023.103592

Acea Nebril, Benigno; García Novoa, Alejandra; Bouzón Alejandro, Alberto; Diaz Carballada, Carlota Czestokowa; Conde Iglesias, Carmen

Statistics

View Usage Statistics

Identifiers

URI: http://hdl.handle.net/20.500.11940/21819

DOI: 10.1016/j.breast.2023.103592

ISSN: 1532-3080

Full record

Services

Files view or download

Acea-Nebril B, García-Novoa A, Bouzón Alejandro A, Díaz Carballada C, Conde Iglesias C. Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients. Breast. 2023;72. (272.3Kb)

Date issued

2023

Journal title

Breast

Type of content

Artigo

MeSH

Abstract

Axillary staging is an important prognostic factor in breast cancer, being sentinel lymph node biopsy (SLNB) the gold standard staging method in early stages. However, in clinically node positive (cN+) patients who converted to clinically node-negative (cN0) after primary systemic therapy (PST) the axillary staging method during surgery remains controversial. There are at least three validated methods: SLNB, targeted axillary dissection (TAD) and marking axillary nodes with radioactive iodine seeds (MARI) procedure. Our house believe that the biopsied and clipped lymph node could predict response to systemic treatment.

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

RUNA digital repository